RVL Pharmaceuticals plc Deferred Tax Liabilities, Net, Noncurrent
RVL Pharmaceuticals plc had Deferred Tax Liabilities, Net, Noncurrent of $24.84 million as of 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxLiabilitiesNoncurrent · last filed 2019-05-09
- 2019-03-31: Deferred Tax Liabilities, Net, Noncurrent $24.84M.
- 2018-12-31: Deferred Tax Liabilities, Net, Noncurrent $26.24M.
- 2018-09-30: Deferred Tax Liabilities, Net, Noncurrent $35.17M; Deferred Tax Liabilities, Net, Noncurrent as first filed $13.12M.
- 2017-12-31: Deferred Tax Liabilities, Net, Noncurrent $42.89M; Deferred Tax Liabilities, Net, Noncurrent as first filed $25.36M.
| Period end | Deferred Tax Liabilities, Net, Noncurrent | Deferred Tax Liabilities, Net, Noncurrent as first filed |
|---|---|---|
| 2019-03-31 | $24.84M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $26.24M 10-Q · filed 2019-05-09 | |
| 2018-09-30 | $35.17M 10-K · filed 2019-03-28 | $13.12M 10-Q · filed 2018-11-08 |
| 2017-12-31 | $42.89M 10-K · filed 2019-03-28 | $25.36M 10-Q · filed 2018-11-08 |